# OnCo record idea-fund-payer-funded-pragmatic-trials (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-fund-payer-funded-pragmatic-trials/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-fund-payer-funded-pragmatic-trials" ;
  schema:name "Payers fund trials of cheaper, shorter or lower-dose versions of expensive treatments"@en ;
  schema:description "Health insurers and national health systems have every reason to find out whether half the dose or half the duration of a costly drug works as well. They would fund those trials directly and keep the savings."@en ;
  schema:url <https://onco.cc/ideas/idea-fund-payer-funded-pragmatic-trials/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.fda.gov/about-fda/oncology-center-excellence/project-optimus> ;
  onco:related <https://onco.cc/ideas/idea-fund-implementation-quota/>, <https://onco.cc/ideas/idea-fund-duration-trial-exclusivity/>, <https://onco.cc/ideas/idea-fund-older-patients-trial-fund/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/ribociclib/> ;
  onco:institutions <https://onco.cc/institutions/nki/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-dose-optimisation/>, <https://onco.cc/bottlenecks/b-drug-pricing/> .